Atrial fibrillation and mortality in patients with acute myocardial infarction: A systematic overview and meta-analysis

Current Cardiology Reports

Volumn 14, Issue 5, 2012, Pages 601-610

  Angeli, Fabio ^a   Reboldi, Gianpaolo ^b   Garofoli, Marta ^b   Ramundo, Elisa ^b   Poltronieri, Cristina ^b   Mazzotta, Giovanni ^b   Ambrosio, Giuseppe ^b   Verdecchia, Paolo ^c  

^a Hospital Media Valle Del Tevere   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c Hospital of Assisi   (Italy)

Author keywords

Acute coronary syndrome; Acute myocardial infarction; Atrial fibrillation; Meta analysis; Mortality; Prognosis

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; Q WAVE; RETROSPECTIVE STUDY; SINUS RHYTHM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTEMATIC REVIEW;

ACUTE CORONARY SYNDROME; ATRIAL FIBRILLATION; HOSPITAL MORTALITY; HUMANS; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS;

EID: 84870588572     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-012-0289-3     Document Type: Article

References (58)

1. Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, Osganian V, et al. Impact of atrial fibrillation on the in-hospital and longterm survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 1990;119:996-1001. (Pubitemid 20155273)
2. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. Eur Heart J. 1999;20:748-54. (Pubitemid 29209908)
3. Pizzetti F, Turazza FM, Franzosi MG, Barlera S, Ledda A, Maggioni AP, et al. Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart. 2001;86:527-32. (Pubitemid 32999863)
4. Wann LS, Curtis AB, Ellenbogen KA, Estes III NA, Ezekowitz MD, Jackman WM, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;123:1144-50.
5. Zicha S, Tsuji Y, Shiroshita-Takeshita A, Nattel S. Beta-blockers as antiarrhythmic agents. Handb Exp Pharmacol. 2006;171:235-66.
6. Corradi D, Callegari S, Maestri R, Benussi S, Alfieri O. Structural remodeling in atrial fibrillation. Nat Clin Pract Cardiovasc Med. 2008;5:782-96.
7. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol. 1997;30:406-13. (Pubitemid 27339320)
8. Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969-74. (Pubitemid 30131697)
9. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J. 2000;140:878-85.
10. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E, et al. Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and Thrombolytic Survey Groups. Circulation. 1998;97:965-70. (Pubitemid 28125468)
11. Behar S, Zahavi Z, Goldbourt U, Reicher-Reiss H. Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. Eur Heart J. 1992;13:45-50.
12. Sakata K, Kurihara H, Iwamori K, Maki A, Yoshino H, Yanagisawa A, et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol. 1997;80:1522-7. (Pubitemid 28011823)
13. Kinjo K, Sato H, Ohnishi Y, Hishida E, Nakatani D, Mizuno H, et al. Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol. 2003;92:1150-4. (Pubitemid 37377822)
14. Behar S, Tanne D, Zion M, Reicher-Reiss H, Kaplinsky E, Caspi A, et al. Incidence and prognostic significance of chronic atrial fibrillation among 5839 consecutive patients with acute myocardial infarction. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Cardiol. 1992;70:816-8.
15. Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol. 2009;104:1317-23.
16. Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson Jr FA, et al. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003;92:1031-6. (Pubitemid 37329526)
17. Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and metaanalysis. Circulation. 2011;123:1587-93.
18. Haynes RB, Wilczynski N, McKibbon KA, Walker CJ, Sinclair JC. Developing optimal search strategies for detecting clinically sound studies in MEDLINE. J Am Med Inform Assoc. 1994;1:447-58.
19. McAuley L, Pham B, Tugwell P, Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet. 2000;356:1228-31.
20. Gregoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol. 1995;48:159-63.
21. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12. (Pubitemid 30214957)
22. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
23. Sutton A, Abrams K, Jones D. Methods for meta-analysis in medical research. Wiley series in probability and statistics. Chichester: John Wiley & Sons LTD; 2000.
24. Whitehead A. Estimating the treatment difference in an individual trial. In: Meta-analysis of controlled clinical trials. Chichester: John Wiley & Sons Ltd; 2002. p. 23-50.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60. (Pubitemid 37088507)
26. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559-73. (Pubitemid 34746063)
27. Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med. 2004;23:1663-82. (Pubitemid 38765338)
28. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676-80. (Pubitemid 43209069)
29. Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail. 2005;7:671-6. (Pubitemid 40733002)
30. Berton G, Cordiano R, Cucchini F, Cavuto F, Pellegrinet M, Palatini P. Atrial fibrillation during acute myocardial infarction: association with all-cause mortality and sudden death after 7-year of follow-up. Int J Clin Pract. 2009;63:712-21.
31. Cristal N, Peterburg I, Szwarcberg J. Atrial fibrillation developing in the acute phase of myocardial infarction. Prognostic implications. Chest. 1976;70:8-11.
32. Fluck DC, Olsen E, Pentecost BL, Thomas M, Fillmore SJ, Shillingford JP, et al. Natural history and clinical significance of arrhythmias after acute cardiac infarction. Br Heart J. 1967;29:170-89.
33. Galcera Tomas J, Melgarejo Moreno A, Garcia Alberola A, Baranco Polo M, Martinez-Lozano Aranaga F, Rodriguez Fernandez S. Incidence, clinical characteristics and prognostic significance of supraventricular tachyarrhythmias in acute myocardial infarction. Rev Esp Cardiol. 1999;52:647-55.
34. Goldberg RJ, Yarzebski J, Lessard D, Wu J, Gore JM. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a communitywide perspective. Am Heart J. 2002;143:519-27. (Pubitemid 34185185)
35. Hunt D, Sloman G, Penington C. Effects of atrial fibrillation on prognosis of acute myocardial infarction. Br Heart J. 1978;40:303-7. (Pubitemid 8313609)
36. Hurwitz M, Eliot RS. Arrhythmias in acute myocardial infarction. Dis Chest. 1964;45:616-26.
37. Klass M, Haywood LJ. Atrial fibrillation associated with acute myocardial infarction: a study of 34 cases. Am Heart J. 1970;79:752-60.
38. Kobayashi Y, Katoh T, Takano T, Hayakawa H. Paroxysmal atrial fibrillation and flutter associated with acute myocardial infarction: hemodynamic evaluation in relation to the development of arrhythmias and prognosis. Jpn Circ J. 1992;56:1-11.
39. Koracevic GP, Petrovic S, Damjanovic M, Stanojlovic T. Association of stress hyperglycemia and atrial fibrillation in myocardial infarction. Wien Klin Wochenschr. 2008;120:409-13.
40. Laurent G, Zeller M, Dentan G, Moreau D, Laurent Y, Beer JC, et al. Prognostic impact of new onset atrial fibrillation in acute non-ST elevation myocardial infarction data from the RICO survey. Heart. 2005;91:369-70. (Pubitemid 40299224)
41. Ledwich JR. A trial of propranolol in myocardial infarction. Can Med Assoc J. 1968;98:988-94.
42. Li K, Huo Y, Ding YS. Clinical profile and outcomes of atrial fibrillation in elderly patients with acute myocardial infarction. Chin Med J (Engl). 2008;121:2388-91.
43. Lopes RD, Pieper KS, Horton JR, Al-Khatib SM, Newby LK, Mehta RH. Short-and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation. Heart. 2008;94:867-73. (Pubitemid 351914696)
44. Madias JE, Patel DC, Singh D. Atrial fibrillation in acute myocardial infarction: a prospective study based on data from a consecutive series of patients admitted to the coronary care unit. Clin Cardiol. 1996;19:180-6. (Pubitemid 26314328)
45. Nielsen FE, Sorensen HT, Christensen JH, Ravn L, Rasmussen SE. Reduced occurrence of atrial fibrillation in acute myocardial infarction treated with streptokinase. Eur Heart J. 1991;12:1081-3.
46. Sankaranarayanan R, James MA, Nuta B, Townsend M, Kesavan S, Burtchaell S, et al. Does atrial fibrillation beget ventricular fibrillation in patients with acute myocardial infarction? Pacing Clin Electrophysiol. 2008;31:1612-9.
47. Sinkovic A. Plasminogen activator inhibitor-1 in patients with atrial arrhythmias during acute myocardial infarction, treated with streptokinase. Blood Coagul Fibrinolysis. 2002;13:741-7. (Pubitemid 36026832)
48. Siu CW, Jim MH, Ho HH, Miu R, Lee SW, Lau CP, et al. Transient atrial fibrillation complicating acute inferior myocardial infarction: implications for future risk of ischemic stroke. Chest. 2007;132:44-9. (Pubitemid 47071765)
49. Suarez G, Herrera M, Vera A, Torrado E, Ferriz J, Arboleda JA. Prediction on admission of in-hospital mortality in patients older than 70 years with acute myocardial infarction. Chest. 1995;108:83-8.
50. Trappolini M, Scorza A, Chillotti FM, Trappolini F, Danese A, De Vito F, et al. Prognostic significance of atrial fibrillation in thrombolysed and non thrombolysed patients. Minerva Cardioangiol. 2006;54:471-9. (Pubitemid 44689843)
51. Kopecky SL. Idiopathic atrial fibrillation: prevalence, course, treatment, and prognosis. J Thromb Thrombolysis. 1999;7:27-31. (Pubitemid 29090118)
52. McMurray J, Kober L, Robertson M, Dargie H, Colucci W, Lopez-Sendon J, et al. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. J Am Coll Cardiol. 2005;45:525-30. (Pubitemid 40222245)
53. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfinkle M, Yusuf S, et al. Prevention of atrial fibrillation with angiotensinconverting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol. 2005;45:1832-9. (Pubitemid 40789940)
54. Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS. Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J. 2005;26:350-6. (Pubitemid 40287380)
55. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:854-906. (Pubitemid 44175743)
56. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;123:e269-367.
57. Van de Werf F, Topol EJ, Lee KL, Woodlief LH, Granger CB, Armstrong PW. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. JAMA. 1995;273:1586-91.
58. Dziewierz A, Siudak Z, Rakowski T, Jakala J, Dubiel JS, Dudek D. Prognostic significance of new onset atrial fibrillation in acute coronary syndrome patients treated conservatively. Cardiol J. 17:57-64.